William Gradishar

William Gradishar at Northwestern University has been a leading authority in breast cancer treatment guidelines as chair of the NCCN Breast Cancer Panel for many years. His clinical research includes studies of nab-paclitaxel and novel chemotherapy combinations in metastatic TNBC. He has contributed to defining the evidence-based management standards for all breast cancer subtypes with particular attention to chemotherapy regimen selection in TNBC. His work in guideline development has influenced the treatment of millions of breast cancer patients globally.